公开(公告)号：US10527633B2

公开(公告)日：2020-01-07

申请号：US15562259

申请日：2016-03-22

申请人： Endothel Pharma ApS

发明人： Sisse Rye Ostrowski ,  Pär Ingemar Johansson

IPC分类号： G01N33/68 ,  G01N33/58 ,  A61K45/06 ,  A61K31/5585

摘要： Use of prostacyclin or an analogue thereof for treatment of a new medical indication in acute critically ill patients, in particular acute critically ill patients with systemic endothelial damage, a biomarker for identifying individuals that have a new medical indication, and a method for identifying a new medical indication.

公开(公告)号：US11714094B2

公开(公告)日：2023-08-01

申请号：US16733802

申请日：2020-01-03

申请人： Endothel Pharma ApS

发明人： Sisse Rye Ostrowski ,  Pär Ingemar Johansson

IPC分类号： G01N33/68 ,  G01N33/58 ,  A61K45/06 ,  A61K31/5585

CPC分类号： G01N33/6893 ,  A61K31/5585 ,  A61K45/06 ,  G01N33/58 ,  G01N33/68 ,  A61K2300/00 ,  A61K31/5585 ,  A61K2300/00

摘要： Use of prostacyclin or an analogue thereof for treatment of a new medical indication in acute critically ill patients, in particular acute critically ill patients with systemic endothelial damage, a biomarker for identifying individuals that have a new medical indication, and a method for identifying a new medical indication.